Saiseikai Maebashi Hospital

Maebashi 371-0821

1 studies enrolling now · 2 studies all time

What they study most

Leukemia, Metabolic Dysfunction-Associated Steatotic Liver Disease

Studies at this site

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML — Running, not enrolling